FDA Grants Approval for Cefixime ANDA218691 by FDC LTD
The FDA has granted approval for the Abbreviated New Drug Application (ANDA) 218691 for Cefixime submitted by FDC LTD.
Asset / Drug
Drug and asset intelligence for Cefixime with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.